Main Session
Sep 29
QP 28 - Actionable Biomarkers: Guiding Therapy Selection and De-escalation

1166 - Real-World Evidence across Prostate RT Modalities: Utilization Shifts, Toxicity and BCR in Genomic Classifier Scored Patients

05:20pm - 05:25pm ET

Presenter(s)

Thomas Kole, MD, PhD Headshot
Thomas Kole, MD, PhD - Valley Health System, Paramus, NJ